Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TTTY25P, or "testis expressed transcript, Y-linked 25, pseudogene," is a pseudogene located on the Y chromosome and is predominantly transcribed in testis. As a pseudogene, it does not encode a functional protein and lacks canonical biological activity associated with drug targets such as receptors, enzymes, or transporters. While some pseudogenes have been found to play regulatory roles in gene expression through various mechanisms (such as acting as competing endogenous RNAs or influencing their parental gene's function), there is *no evidence* that TTTY25P exerts such functions. The presence of this pseudogene may be noted in genome annotation and expression studies, but it is *not considered a therapeutic target or disease gene* by any current biomedical sources.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Testis expressed transcript, Y-linked 25, pseudogene (TTTY25P).